Lessons from effect of etelcalcetide on left ventricular hypertrophy in patients with end-stage kidney disease

Patients with end-stage kidney disease (ESKD) frequently develop left ventricular hypertrophy (LVH), which is associated with an exceptionally high risk of cardiovascular events and mortality. This review focuses on interventional studies that modify levels of fibroblast growth factor 23 (FGF23) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Dörr, Katharina, Kainz, Alexander, Oberbauer, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
MINERAL METABOLISM: Edited by Aline Martin and Tamara Isakova
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394497/
https://www.ncbi.nlm.nih.gov/pubmed/35703173
http://dx.doi.org/10.1097/MNH.0000000000000799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394497/
https://www.ncbi.nlm.nih.gov/pubmed/35703173
http://dx.doi.org/10.1097/MNH.0000000000000799

Ejemplares similares